Howard Jacob, Chief Genomics Officer, VP of Genomic Medicine and Faculty Investigator at the HudsonAlpha Institute for Biotechnology.
Chapters:
0:00 Clinical sequencing since Nic Volker
6:15 30 million Americans with a rare disease
10:07 Ultimate goal is de novo assembly
14:08 Are newly discovered structural variants being used in the clinic
18:11 Obstacles for the adoption of genomic medicine
22:59 Preview of first teaching class
Here’s a title for you. Chief Genomics Officer. Today’s guest is also the VP of Genomic Medicine and a faculty investigator at the HudsonAlpha Institute for Biotechnology.
He launched the world’s first genomic medicine program becoming the first person in history to use genome sequencing to diagnose, treat, and cure a patient. Few people exude the sheer force and vision for the future of genomic medicine that comes from Howard Jacob. We’re very pleased to have him on Mendelspod for the first time to talk about progress with rare disease, sequencing technology, and how he would teach genomic medicine to young people today . . . And of course, that genomic age old question: the exome or the whole genome?
